Presymptomatic investigation after sudden cardiac death in the family;Presymptomatisch onderzoek na plotselinge hartdood in de familie

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 32, 1999, Pages 1643-1648

  Wilde, A A M ^a,b   Van Langen, I M ^a   Van Tintelen, J P ^a,c   Hauer, R N W ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Academisch Ziekenhuis   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

AUTOSOMAL DOMINANT INHERITANCE; CARDIOMYOPATHY; CHEMOPROPHYLAXIS; CLINICAL FEATURE; DEFIBRILLATION; DISEASE ASSOCIATION; ELECTROCARDIOGRAPHY; FAMILIAL DISEASE; GENETIC SCREENING; HEALTH CARE COST; HEART DISEASE; HEART PACING; HEART RIGHT BUNDLE BRANCH BLOCK; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; LONG QT SYNDROME; REVIEW; ST SEGMENT ELEVATION; SUDDEN DEATH;

CARDIOVASCULAR DISEASES; DEATH, SUDDEN, CARDIAC; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; GENETIC SCREENING; HUMANS;

EID: 0033533232     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (25)

1. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, Vincent GM. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. Circulation 1996;94:1996-2012.
2. Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995;92:2929-34.
3. Schwartz PJ, Moss AJ, Priori SG, Wang Q, Lehmann MH, Timothy K, et al. Gene-specific influence on the triggers for cardiac arrest in the long QT syndrome [abstract]. Circulation 1997;96:1-212.
4. Wilde AAM, Jongbloed RJE, Doevendans PA, Düren DR, Hauer RNW, Langen IM van, et al. Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1 ). J Am Coll Cardiol 1999; 33:327-32.
5. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998;339:960-5.
6. Schwartz PJ. Idiopathic long OT syndrome: progress and questions. Am Heart J 1985;109:399-411.
7. Zareha W, Moss AJ, Ie Cessie S, Locati EH, Robinson JL, Hall WJ, et al. Risk of cardiac events in family members of patients with long QT syndrome. J Am Coll Cardiol 1995;26:1685-91.
8. Alings AMW, Wilde AAM. The Brugada syndrome. Clinical data and suggested pathophysiological mechanism. Circulation 1999;99: 666-73.
9. 3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97:457-60.
10. Wilde AAM, Alings AMW, Wever EFD, Derksen R, Hauer RNW. Het ene 'rechter bundeltakblok' is het andere niet. Cardiologie 1998;5:380-3.
11. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293-6.
12. Schwartz K, Carrier L, Guicheney P, Komajda M. Molecular basis of familial cardiomyopathies. Circulation 1995;91:532-40.
13. Bonne G, Carrier L, Richard P, Hainque B, Schwartz K. Familial hypertrophic cardiomyopathy: from mutations to functional defects. Cire Res 1998;83:580-93.
14. Maron BJ, Savage DD, Wolfson JK, Epstein SE. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hyperthrophic cardiomyopathy: a prospective study. Am J Cardiol 1981;48:252-7.
15. Sadoul N, Prasad K, Elliott PM, Bannerjee S, Frenneaux MP, McKenna WJ. Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy. Circulation 1997;96:2987-91.
16. Saumarez RC, Slade AKB, Grace AA, Sadoul N, Camm AJ, McKenna WJ. The significance of paced electrogram fractionation in hypertrophic cardiomyopathy. A prospective study. Circulation 1995;91:2762-8.
17. Watkins H, McKenna WJ, Thierfelder L, Suk HJ, Anan R, O'Donoghue, et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hyperthrophic cardiomyopathy. N Engl J Med 1995;331:1058-64.
18. McKenna WJ, Spirito P, Desnos M, Duhourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart 1997;77:130-2.
19. Mestroni L, Giacca M. Molecular genetics of dilated cardiomyopathy. Curr Opin Cardiol 1997;12:303-9.
20. Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 1998;280:750-2.
21. Goldfarb LG, Park KY, Cervenakova L, Gorokhova S, Lee HS, Vasconcelos O, et al. Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 1998;19:402-3.
22. Cowburn PJ, Cleland JGF, Coats AJS, Komajda M. Risk stratification in chronic heart failure. Eur Heart J 1998;19:696-710.
23. KNMG. Artsen en genen. Aanbevelingen inzake genetica van het hoofdbestuur van de KNMG voor de algemene vergadering. Med Contact 1998;53:551-5.
24. Tibben A. What is knowledge hut grieving. On psychosocial effects of presymptomatic DMA-testing for Huntington's disease [proefschrift]. Rotterdam: Erasmus Universiteit; 1993.
25. Grosfeld FJM, Lips CJM, Beemer FA, Spijker HG van, Brouwers-Smalbraak GJ, Kroode HFJ ten. Psychological risks of genetically testing children for a heriditary cancer syndrome. Patient Educ Couns 1997;32:63-7.